Table 2.
Variables | Group | Group difference (95% CI) | p | ||
---|---|---|---|---|---|
Case (n = 12) | Control (n = 12) | ||||
NaF | |||||
Intervertebral discs | SUVmax | 11.63 ± 3.29 | 9.45 ± 1.32 | 2.18 (0.15–4.21) | 0.038 |
SUVmean | 2.75 (1.82–7.02) | 2.55 (1.88–3.45) | 0.64 (−0.35 to 1.64) | 0.21a | |
SUVtotal | 76.73 ± 31.02 | 73.21 ± 22.60 | 3.51 (−16.88 to 23.91) | 0.71 | |
Facet joints | SUVmax | 13.5 (7.23–33.98) | 9.17 (8.25–17.69) | 4.38 (1.08–7.68) | 0.015a |
SUVmean | 5.04 (3.53–7.8) | 4.15 (3.42–7.21) | 0.47 (−0.53 to 1.47) | 0.41a | |
SUVtotal | 203 ± 48.60 | 196.92 ± 46.01 | 6.07 (−30.61 to 42.76) | 0.72 | |
Lumbar vertebral bodies | SUVmax | 14.67 ± 4.17 | 12.72 ± 1.96 | 1.95 (−0.71 to 4.61) | 0.13 |
SUVmean | 7.80 ± 1.98 | 7.29 ± 0.78 | 0.51 (−0.72 to 1.74) | 0.38 | |
SUVtotal | 1660.03 ± 503.91 | 1511.30 ± 205.81 | 148.74 (−101.88 to 399.35) | 0.21 | |
FDG | |||||
Intervertebral discs | SUVmax | 2.83 ± 1.04 | 2.26 ± 0.57 | 0.57 (−0.07 to 1.21) | 0.08 |
SUVmean | 0.96 ± 0.34 | 0.69 ± 0.15 | 0.27 (0.05–0.49) | 0.021 | |
SUVtotal | 21.72 ± 7.76 | 19.82 ± 7.68 | 1.9 (−5.69 to 9.49) | 0.59 | |
Facet joints | SUVmax | 2.47 (1.96–4.87) | 2.84 (1.75–4.88) | −0.34 (−1.2 to 0.52) | 0.35a |
SUVmean | 0.99 ± 0.26 | 0.96 ± 0.20 | 0.03 (−0.19 to 0.26) | 0.74 | |
SUVtotal | 38.41 ± 4.79 | 42.18 ± 12.96 | −3.77 (−13.12 to 5.58) | 0.39 | |
Lumbar vertebral bodies | SUVmax | 3.77 ± 0.90 | 3.47 ± 1.06 | 0.3 (−0.6 to 1.2) | 0.48 |
SUVmean | 1.75 ± 0.40 | 1.69 ± 0.40 | 0.06 (−0.3 to 0.43) | 0.7 | |
SUVtotal | 385.77 ± 137.84 | 359.15 ± 118.67 | 26.62 (−70.53 to 123.79) | 0.55 |
Abbreviations: CI, confidence interval; FDG, fluorodeoxyglucose; NaF, sodium fluoride; SUV, standardized uptake value.
Wilcoxon matched‐pairs test was used.